Zeford 2 Tablet contains Clonazepam 2mg, a benzodiazepine class medication primarily indicated for the management of seizure disorders, including absence seizures, myoclonic seizures, and Lennox-Gastaut syndrome. It exerts its therapeutic effect by enhancing the activity of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter in the central nervous system, thereby producing a calming effect on neuronal excitability. Zeford 2 is also utilized in the treatment of panic disorder with or without agoraphobia, providing anxiolytic benefits through its sedative and muscle-relaxant properties. The onset of action is typically rapid, making it suitable for acute management, though it may also be used for long-term control under careful medical supervision. Dosage should be individualized based on patient response and clinical condition, with gradual titration to minimize adverse effects such as drowsiness, dizziness, and cognitive impairment. Prolonged use may lead to tolerance, dependence, and withdrawal symptoms; therefore, it is recommended to avoid abrupt discontinuation. Caution is advised in patients with respiratory insufficiency, hepatic impairment, or a history of substance abuse. Zeford 2 should be used under strict medical guidance to ensure safety and efficacy.